These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1880 related items for PubMed ID: 30431207

  • 1. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z, Wei X, Shen L, Zhu H, Zheng X.
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [Abstract] [Full Text] [Related]

  • 2. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y, Li H, Yi D, Bai Y, Zhong S, Liu Q, Chen Y, Zhao G.
    Cancer Lett; 2018 Oct 28; 435():66-79. PubMed ID: 30081068
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O6-methylguanine DNA methyltransferase (MGMT) expression and reactive oxygen species (ROS)-mediated DNA damage in glioblastoma.
    Jin L, Kiang KM, Cheng SY, Leung GK.
    Lab Invest; 2022 Feb 28; 102(2):194-203. PubMed ID: 34625658
    [Abstract] [Full Text] [Related]

  • 4. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines.
    Lombardi F, Augello FR, Artone S, Gugu MK, Cifone MG, Cinque B, Palumbo P.
    Int J Mol Sci; 2022 Jan 28; 23(3):. PubMed ID: 35163465
    [Abstract] [Full Text] [Related]

  • 5. AP-2α decreases TMZ resistance of recurrent GBM by downregulating MGMT expression and improving DNA damage.
    Huang G, Ouyang M, Xiao K, Zhou H, Zhong Z, Long S, Li Z, Zhang Y, Li L, Xiang S, Ding X.
    Life Sci; 2024 Nov 15; 357():123111. PubMed ID: 39369843
    [Abstract] [Full Text] [Related]

  • 6. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G, Sun Y, Hong R, Xiong J, Lu Y, Liu Y, Lu J, Zhang Z, Guo C, Nan Y, Huang Q.
    Clin Transl Oncol; 2020 Aug 15; 22(8):1252-1262. PubMed ID: 31865606
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional control of O6 -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma.
    Happold C, Stojcheva N, Silginer M, Weiss T, Roth P, Reifenberger G, Weller M.
    J Neurochem; 2018 Mar 15; 144(6):780-790. PubMed ID: 29480969
    [Abstract] [Full Text] [Related]

  • 8. Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p.
    Wu P, Cai J, Chen Q, Han B, Meng X, Li Y, Li Z, Wang R, Lin L, Duan C, Kang C, Jiang C.
    Nat Commun; 2019 May 03; 10(1):2045. PubMed ID: 31053733
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
    Yang HC, Wang JY, Bu XY, Yang B, Wang BQ, Hu S, Yan ZY, Gao YS, Han SY, Qu MQ.
    J Cell Physiol; 2019 May 03; 234(5):6783-6800. PubMed ID: 30317578
    [Abstract] [Full Text] [Related]

  • 10. NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells.
    Tsuji S, Nakamura S, Shoda K, Yamada T, Shimazawa M, Nakayama N, Iwama T, Hara H.
    J Neurooncol; 2022 Nov 03; 160(2):375-388. PubMed ID: 36308592
    [Abstract] [Full Text] [Related]

  • 11. Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
    Yamada T, Tsuji S, Nakamura S, Egashira Y, Shimazawa M, Nakayama N, Yano H, Iwama T, Hara H.
    J Neurosurg; 2021 Mar 01; 134(3):701-710. PubMed ID: 32168477
    [Abstract] [Full Text] [Related]

  • 12. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W, Yan D, Song Z, Zhu X, Liu X, Li X, Zhao S.
    Life Sci; 2019 Jun 01; 226():98-106. PubMed ID: 30980849
    [Abstract] [Full Text] [Related]

  • 13. Unveiling the role of TAGLN2 in glioblastoma: From proneural-mesenchymal transition to Temozolomide resistance.
    Li Y, Wang X, Xu T, Xu F, Chen T, Li Z, Wang Y, Chen H, Ming J, Cai J, Jiang C, Meng X.
    Cancer Lett; 2024 Aug 28; 598():217107. PubMed ID: 38992489
    [Abstract] [Full Text] [Related]

  • 14. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
    Lan F, Pan Q, Yu H, Yue X.
    J Neurochem; 2015 Sep 28; 134(5):811-8. PubMed ID: 25991372
    [Abstract] [Full Text] [Related]

  • 15. SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down-regulation of MGMT.
    Tsai CK, Huang LC, Wu YP, Kan IY, Hueng DY.
    FASEB J; 2019 Dec 28; 33(12):14171-14184. PubMed ID: 31725331
    [Abstract] [Full Text] [Related]

  • 16. Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway.
    Hu YH, Jiao BH, Wang CY, Wu JL.
    CNS Neurosci Ther; 2021 May 28; 27(5):552-563. PubMed ID: 33460245
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
    Yu Z, Chen Y, Wang S, Li P, Zhou G, Yuan Y.
    Cancer Lett; 2018 Aug 01; 428():77-89. PubMed ID: 29705182
    [Abstract] [Full Text] [Related]

  • 18. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X, Wang M, Zuo J, Wahafu A, Mao P, Li R, Wu W, Xie W, Wang J.
    Life Sci; 2019 Nov 01; 236():116917. PubMed ID: 31614149
    [Abstract] [Full Text] [Related]

  • 19. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
    Ho KH, Cheng CH, Chou CM, Chen PH, Liu AJ, Lin CW, Shih CM, Chen KC.
    Pharmacol Res; 2019 Sep 01; 147():104390. PubMed ID: 31398406
    [Abstract] [Full Text] [Related]

  • 20. Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway.
    Fei YQ, Shi RT, Zhou YF, Wu JZ, Song Z.
    Neurochem Int; 2022 Jul 01; 157():105348. PubMed ID: 35490896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 94.